BioPharm International - Articles on bioprocessing methods, regulatory compliance, and biotech strategies
  • Search
  • Suppliers
  • Careers

Enter a company or product name

KeywordLocation
About Search
ASBPE

ADVERTISEMENT

ONLINE EXCLUSIVE

Sustaining Operational Excellence Improvements
FindPharma
Featured Jobs

More Jobs

Author Guidelines
BioPharm International
Twitter

BIO VIDCASTS
Editorial
Quality by Design:

What We Learned from the Biologics QbD Case Study

Previous StoryPlay / PauseNext Story
Episode Number 5: Advancing Peptide Mapping with Informatics Support for Multiplexed Peptide Fragmentation Data
Extractables & Leachables Testing for Single-Use Bioprocessing Equipment Assessing Risk, Leveraging Knowledge, and Protecting Patients
Biopharmaceutical Job Market: 2010 and Beyond
Quality by Design in Biotech: Keys to Implementation
Podcast:Pfizer´s Maddaluna on Integrating Wyeth´s Manufacturing Organization

From the Editor
Regulatory Relief: An Idea Whose Time Has Come

Perspectives on Outsourcing
Supplier Quality Management: A Risk-Based Approach

Compliance Notes
Quality by Design and Compliance Readiness

Burrill on Biotech
Biotech Remains Upbeat During the Summer

Final Word
QbD: A Roadmap to Adoption

FDA Unveils Initiative to Reduce Unnecessary Radiation Exposure from Medical Imaging
FDA Updates Statement on the Investigation into the Salmonella Montevideo Outbreak
FDA Issues Guidance to Help Streamline Medical Device Clinical Trials
United States Seizes more than 1500 Cases of Food from Wisconsin Distribution Warehouse
FDA Approves Xiaflex for Debilitating Hand Condition

Watson Pharmaceuticals Acquires Eden Biodesign
February 4, 2010
FDA Requests $4.03 Billion for FY2011-a 23% Increase
February 1, 2010
AstraZeneca Drops the Axe Again and Cuts 8,000 Jobs
January 29, 2010
Sanofi Pasteur Partners with KaloBios on Novel Biologic for P. aeruginosa Infections
January 15, 2010
Gender Gap is Getting Narrower in the Biopharmaceutical Sector
January 15, 2010
Issues and Opportunities Challenge Biotech Manufacturers
Demand for new vaccines and therapies in 2010 will be offset by concerns about drug prices and product safety.
BioPharm International - January 1, 2010
The Promise and Perils of Vaccines
Vaccine research and development is surging, but continues to face manufacturing and regulatory challenges.
BioPharm International - December 1, 2009
Safety First in Biotech Development
Heightened attention to product safety issues is slowing the approval process for new therapies.
BioPharm International - November 1, 2009
Charts & Trends
See the charts. Understand the trends.
Where will biopharma hiring take place in 2013?

Click for complete article

 
Residual Solvents: Alternate Validated Methods
October 30, 2009
Rapid Growth of Full Time Equivalent Staffing Programs
October 5, 2009
Monoclonal Antibody Purification Using UNOsphere SUPrA Media-BioRad Whitepaper
June 15, 2009
Accelerating Innovation with Enterprise Content Management
BioPharm International - December 18, 2008
Characterizing Powders
September 1, 2007
Click here